Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mini-review: Foldosome regulation of androgen receptor action in prostate cancer.
Cano LQ, Lavery DN, Bevan CL. Cano LQ, et al. Among authors: bevan cl. Mol Cell Endocrinol. 2013 Apr 30;369(1-2):52-62. doi: 10.1016/j.mce.2013.01.023. Epub 2013 Feb 8. Mol Cell Endocrinol. 2013. PMID: 23395916 Review.
The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1.
Bevan CL, Hoare S, Claessens F, Heery DM, Parker MG. Bevan CL, et al. Mol Cell Biol. 1999 Dec;19(12):8383-92. doi: 10.1128/mcb.19.12.8383. Mol Cell Biol. 1999. PMID: 10567563 Free PMC article.
The role of coactivators in steroid hormone action.
Bevan C, Parker M. Bevan C, et al. Exp Cell Res. 1999 Dec 15;253(2):349-56. doi: 10.1006/excr.1999.4719. Exp Cell Res. 1999. PMID: 10585257 Review. No abstract available.
Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1.
Sheppard HM, Harries JC, Hussain S, Bevan C, Heery DM. Sheppard HM, et al. Among authors: bevan c. Mol Cell Biol. 2001 Jan;21(1):39-50. doi: 10.1128/MCB.21.1.39-50.2001. Mol Cell Biol. 2001. PMID: 11113179 Free PMC article.
Androgens target prohibitin to regulate proliferation of prostate cancer cells.
Gamble SC, Odontiadis M, Waxman J, Westbrook JA, Dunn MJ, Wait R, Lam EW, Bevan CL. Gamble SC, et al. Among authors: bevan cl. Oncogene. 2004 Apr 15;23(17):2996-3004. doi: 10.1038/sj.onc.1207444. Oncogene. 2004. PMID: 14968116
Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
Powell SM, Christiaens V, Voulgaraki D, Waxman J, Claessens F, Bevan CL. Powell SM, et al. Among authors: bevan cl. Endocr Relat Cancer. 2004 Mar;11(1):117-30. doi: 10.1677/erc.0.0110117. Endocr Relat Cancer. 2004. PMID: 15027889
Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
Whitaker HC, Hanrahan S, Totty N, Gamble SC, Waxman J, Cato AC, Hurst HC, Bevan CL. Whitaker HC, et al. Among authors: bevan cl. Clin Cancer Res. 2004 Nov 1;10(21):7392-401. doi: 10.1158/1078-0432.CCR-04-0388. Clin Cancer Res. 2004. PMID: 15534116
Hey1, a mediator of notch signaling, is an androgen receptor corepressor.
Belandia B, Powell SM, GarcĂ­a-Pedrero JM, Walker MM, Bevan CL, Parker MG. Belandia B, et al. Among authors: bevan cl. Mol Cell Biol. 2005 Feb;25(4):1425-36. doi: 10.1128/MCB.25.4.1425-1436.2005. Mol Cell Biol. 2005. PMID: 15684393 Free PMC article.
Androgen receptor in prostate cancer: cause or cure?
Bevan CL. Bevan CL. Trends Endocrinol Metab. 2005 Nov;16(9):395-7. doi: 10.1016/j.tem.2005.09.006. Epub 2005 Oct 3. Trends Endocrinol Metab. 2005. PMID: 16202619
Prohibitin, a protein downregulated by androgens, represses androgen receptor activity.
Gamble SC, Chotai D, Odontiadis M, Dart DA, Brooke GN, Powell SM, Reebye V, Varela-Carver A, Kawano Y, Waxman J, Bevan CL. Gamble SC, et al. Among authors: bevan cl. Oncogene. 2007 Mar 15;26(12):1757-68. doi: 10.1038/sj.onc.1209967. Epub 2006 Sep 11. Oncogene. 2007. PMID: 16964284
55 results
Jump to page